Uniti Group (NASDAQ:UNIT) Stock, Quote.Headers.trade-ideas

Uniti Group

Uniti is a REIT with about 140,000 route miles of fiber in the us, primarily in the Southeast. It has agreed to merge with Windstream, which will result in Uniti giving up its REIT status and adding a consumer telecom business line. Uniti's business currently consists exclusively of fiber leasing to enterprises. Windstream currently leases the Uniti network and makes up the bulk of Uniti's revenue and profits. The combined firm will own 217,000 route miles of fiber and pass 4.3 million households and 150,000 commercial buildings, mostly in less populated markets in the Southeast. The firm will continue to offer fiber access to enterprises, as Uniti currently does, but residential telecom services will become its largest revenue stream.

xr:d:DAFlJKNXbrw:2,j:4527636209394207909,t:23060712

News

Intraday Update

Markets

Movers

Trading Ideas

APLD

DLTR

GIII

Larimar Therapeutics, Inc. - Common Stock

LRMR

MYGN

PPTA

PRMW

PSNY

QDEL

SATS

SCVL

UNIT

VSTS

YEXT

ZETA

G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday

3 titoli immobiliari con dividendi superiori al 7% consigliati da Wall Street

Dividends

Price Target

Pre-Market Outlook

Analyst Ratings

CLPR

Wall Street&#39;s Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 7% Dividend Yields

Pick,Up,House,Model,Over,Coin,Stacks

Long Ideas

CHCT

Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains This Month

Uniti Group Inc

UNITE Group PLC

UNITED AIRLINES HOLDINGS ORD

UNITED BANK 144A

UNITED BANK GDR

UNITED BULLION EXCH INC by United Bullion Exchange, Inc.

UNITED CORPS LTD by United Corporations Limited

UNITED E&P INC by United E & P, Inc.

UNITED Inc

UNITED PALM OIL INDST PCL by United Palm Oil Industry Public Co Ltd

UNITED PARCEL SERVICE CL B ORD

UNITED RENTAL ORD

UNITED STATES OIL ETF

UNITED WORLD HLDG GRP LTD by United World Holding Group Ltd.

UNITEDHEALTH GRP ORD

UNITI GROUP ORD

UNITY BIOTECHNOLOGY ORD

Unit Corp

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings Inc

UNITED AMERICAN CORP by United American Corp.

United American Corp

UNITED AMER HEALTHCARE CP by United American Healthcare Corp.

United American Healthcare Corp

UNITED AMERICAN PETR by United American Petroleum Corp.

United American Petroleum Corp

UNITED ARROWS UNSP/ADR by United Arrows Ltd.

United Arrows Ltd

United Bancorp Inc

UNITED BNCRP OF AL INC A by United Bancorporation of Alabama, Inc.

United Bancorp Of Alabama Inc

UNITED BNCSHS CLMBUS GRVE by United Bancshares, Inc.

United Bancshares Inc

UNITED BANK LTD GDR 144A by United Bank Ltd.

United Bank Ltd

United Bankshares Inc

Compania Cervecerias Unidas, S.A. Common Stock

United Breweries Co Inc

United Communications Partners Inc

United Community Banks, Inc. Common Stock

United Community Banks Inc

United Community Banks, Inc. Depositary Shares, each representing 1/1000th interest in a share of Series I Non-Cumulative Preferred Stock

UNITED CONSORTIUM LTD by United Consortium Ltd.

United Consortium Ltd

UNITED ENERGY CRP NEV by United Energy Corp.

United Energy Corp

UNITED ENERGY GRP LTD ORD by United Energy Group, Ltd.

United Energy Group Ltd

United Ethanol LLC

UNITED EXPRESS INC by UNITED EXPRESS INC.

United Express Inc

United Fire Group Inc

United Hampshire US REIT

UNITED HEALTH PRODUTS INC by United Health Products, Inc.

United Health Products Inc

United Homes Group, Inc - Class A Common Stock

United Homes Group Inc

UNITED INTERNET UNSP/ADR by United Internet AG

United Internet AG

UNITED INTERNET AG&CO REG by United Internet AG

UNITED LABS INTL HLDG ORD by United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd

United Lithium Corp

UNITED LITHIUM CORP by United Lithium Corp.

United Malt Group Ltd Ordinary Shares

United Maritime Corporation - Common Stock

United Maritime Corp

United Microelectronics Corporation (NEW) Common Stock

United Microelectronics Corp

UNITED NATL BK CAIRO GA by United National Bank (Cairo, GA)

United National Bank

United Natural Foods Inc

UNITED OVRSEAS BK S/ADR by United Overseas Bank Ltd.

United Overseas Bank Ltd

UNITED OVERSEAS BANK ORD by United Overseas Bank Ltd.

United Parcel Service Inc

United Parks & Resorts Inc

UNITED PLANT BERHAD ORD by United Plantations Berhad

United Plantation Bhd

United Rail Inc

United Rentals Inc

UNITED RES HLDGS GRP INC by United Resource Holdings Group, Inc.

United Resources Holdings Group Inc

UNITED ROYALE HLDGS CORP by United Royale Holdings Corp.

United Royale Holdings Corp

United Security Bancshares - Common Stock

United Security Bancshares

United States 12 Month Natural Gas Fund

United States 12 Month Oil

United States Antimony Corporation Common Stock

United States Antimony Corp

United States Basketball League Inc

United States Brent Oil Fund, LP ETV

United States Cellular Corporation Common Stock

United States Cellular Corp

United States Cellular Corporation 5.500% Senior Notes due 2070

United States Cellular Corporation 6.250% Senior Notes due 2069

United States Commodity Index Fund ETV

United States Copper Index Fund ETV

United States Gasoline Fund LP

United States Lime & Minerals, Inc. - Common Stock

United States Lime & Minerals Inc

United States Natural Gas Fund LP

United States Oil Fund

United States Steel Corporation Common Stock

United States Steel Corp

UNITED SUPER MKTS HLDGS by UNITED SUPER MKTS HLDGS INC.

United Super Markets Holdings Inc

UNITED TENNESSEE BNKSHS by United Tennessee Bankshares, Inc.

United Tennessee Bankshares Inc

United Therapeutics Corporation - Common Stock

United Therapeutics Corp

UNITED URBAN INVT CORP by United Urban Investment Corp.

United Urban Investment Corp

UNITED UTIL GRP S/ADR PLC by United Utilities Group PLC

United Utilities Group PLC

UNITED UTILITIES GRP ORD by United Utilities Group PLC

United-Guardian Inc

UnitedHealth Group Incorporated Common Stock (DE)

UnitedHealth Group Inc

Unitika Ltd

Unitil Corp

Unitrend Entertainment Group Ltd

Unitronix Corp

Unity Bancorp Inc

Unity Biotechnology Inc

Unity Software Inc

Unity Wealth Partners Dynamic Capital Appreciation & Options ETF

&#8220;Shark Tank&#8221; fame billionaire Mark Cuban recently slammed hedge fund manager and founder of Pershing Square Capital Management Bill Ackman&#8217;s views on the candidacy of Kamala Harris.
What Happened: Cuban responded to a post by Bill Ackman, which criticized Harris&#8217;s candidacy and the circumstances surrounding her rise to the presidential nominee position. Ackman accused Harris of being complicit in what he called &#8220;the greatest lie ever told to the American people by our government,&#8221; referring to the health status of former President Joe Biden.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Let's not forget that <a href="https://twitter.com/POTUS?ref_src=twsrc%5Etfw">@POTUS</a> Biden was the Democratic presidential candidate 63 days ago. We were told by the administration and the media that Biden was in perfect health and that videos of him exhibiting serious deterioration were ‘right wing propaganda.' Then, threatened… <a href="https://t.co/QHtVdhawJY">https://t.co/QHtVdhawJY</a>
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1837777743464865852?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/09/40953535/anybody-who-votes-for-a-democrat-or-kamala-worst-you-should-have-your-head-examined-trump-tells-vote?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Anybody Who Votes For A Democrat Or Kamala, Worst…You Should Have Your Head Examined:&#8217; Trump Tells Voter</a>
Ackman also expressed his disappointment with Harris&#8217;s campaign strategy, accusing her of evading direct questions about the economy, the border, or foreign policy. He suggested that her campaign was a blatant attempt to say what she needs to say to get elected.
Cuban said in <a href="https://x.com/mcuban/status/1837833875571069414?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1837833875571069414%7Ctwgr%5E8e4c71f4fa37fc5a73a1c473e778646c0b22e9c3%7Ctwcon%5Es1_c10&amp;ref_url=https%3A%2F%2Feditorial.benzinga.com%2Fwp-admin%2Fpost.php%3Fpost%3D560083action%3Dedit">response</a>: &#8216;When the competition hires a new CEO and she is kicking your a&#x2A;&#x2A; …&#8217;
Why It Matters: Cuban&#8217;s critical response to Ackman&#8217;s thread comes amidst a <a href="https://www.benzinga.com/news/24/09/40971721/voters-warm-to-kamala-harris-as-election-nears">surge in Harris&#8217;s popularity</a> Recent polls suggest a slight advantage for Harris over Trump, with a Morning Consult poll showing Harris leading by 6 percentage points nationwide.
Notably, Cuban, a supporter of the vice president, had previously expressed some skepticism about Harris&#8217;s economic proposals. In August, he engaged in a storm of posts about Harris&#8217;s economic plans, particularly around the <a href="https://www.benzinga.com/personal-finance/24/08/40544099/mark-cuban-responds-to-kamala-harris-economic-plan-with-dozens-of-tweets-says-she-didnt-mention-">issue of price controls</a>.
Cuban&#8217;s relationship with Donald Trump, the other presidential candidate, has been <a href="https://www.benzinga.com/startups/24/08/40582769/mark-cuban-now-calls-trump-a-snake-oil-salesperson-but-reveals-they-were-once-so-friendly-that-trump">complicated</a>. He once referred to Trump as a &#8220;snake oil salesperson,&#8221; but admitted they were once on good terms, with the former president even seeking his advice on stocks at one point.
Photo courtesy: Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

General

Mark Cuban Issues A Stinging Retort To Bill Ackman's Attack On Kamala Harris: 'She Is Kicking Your A**…'

Former President Donald Trump has declared that he will not pursue another presidential run if he is defeated in the forthcoming November election.
What Happened: Trump, in a conversation with Sinclair Broadcast Group&#8217;s &#8220;Full Measure&#8221; on Sunday, dismissed the idea of another presidential run if he loses the upcoming election, as reported by <a href="https://abcnews.go.com/Politics/trump-run-loses-november/story?id=113910212">ABC News</a>.
When asked by host Sharyl Attkisson about another run, he replied, &#8220;I don&#8217;t see that at all. I think that, hopefully, we&#8217;re going to be successful.&#8221;
Trump, currently the oldest presidential nominee in history, is in the race following President Biden&#8217;s decision not to run for the 2024 election. Age and mental acuity have been significant concerns in this election cycle.
Amid his third presidential bid, Trump has been balancing his campaign activities with court appearances related to four criminal cases against him.
See Also: <a href="https://www.benzinga.com/24/09/40954613/kim-jong-uns-show-of-force-with-missiles-indicates-north-korea-is-no-longer-interested-in-negotiatio?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Kim Jong Un&#8217;s &#8216;Show Of Force&#8217; With Missiles Indicates North Korea Is No Longer Interested In Negotiations</a>
Why It Matters: The 2024 presidential election has seen a tight contest between Trump and Vice President Kamala Harris. Recent polling data, including over 20 swing-state polls conducted post the September 10 debate, suggests a <a href="https://www.benzinga.com/news/24/09/40969584/trump-vs-harris-this-candidate-has-the-edge-in-latest-swing-state-polls">slight lead</a> for Harris over Trump. 
Despite Harris trending upwards in the polls, Trump has been <a href="https://www.benzinga.com/general/politics/24/09/40949853/harris-in-trouble-new-swing-state-poll-shows-trump-gains-ground-in-key-battleground-areas-for-20">gaining ground</a> in key battleground areas. The election could hinge on the results from these swing states. 
Meanwhile, Harris has seen a surge in popularity with a <a href="https://www.benzinga.com/news/24/09/40971721/voters-warm-to-kamala-harris-as-election-nears">significant uptick</a> in her favorability. This shift is noteworthy, given her previously low polling figures. 
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Trump Says No To Another Run If He Loses 2024 Election To Kamala Harris: 'Hopefully, We're Going To Be Successful'

House GOP leaders have put forth a three-month plan to keep the government funded, in the wake of Speaker Mike Johnson&#8217;s (R-La.) initial plan failing due to Republican opposition.
What Happened: The continuing resolution (CR) was a product of bipartisan negotiations in the House and Senate. The resolution, which maintains current funding levels until December 20, sets the stage for a holiday funding battle. The three-month timeframe is a reduction from Johnson&#8217;s initial six-month proposal and notably omits a Donald Trump-endorsed measure requiring proof of citizenship to vote, <a href="https://thehill.com/homenews/house/4892931-government-funding-continuing-resolution-deal-mike-johnson/">reported</a> The Hill.
Republican leaders aim to bring the bill to a floor vote by Wednesday, with the goal of sending it to the Senate before the September 30 shutdown deadline. Johnson warned Republicans against a shutdown, stating in a &#8220;Dear Colleague&#8221; letter, &#8220;As history has taught and current polling affirms, shutting the government down less than 40 days from a fateful election would be an act of political malpractice.&#8221;
The bill also earmarks $231 million for the Secret Service, which has recently come under scrutiny following an apparent second assassination attempt against former President Trump. Johnson characterized the legislation as &#8220;a very narrow, bare-bones CR including only the extensions that are absolutely necessary.&#8221;
House Republicans will likely require Democratic support to pass the legislation, as many GOP lawmakers are anticipated to oppose the bill due to the lack of spending cuts, shorter timeframe, and exclusion of the voting bill. The bill&#8217;s passage may face obstacles as it will need to clear a procedural vote, which are traditionally party-line affairs.
See Also: <a href="https://www.benzinga.com/news/24/09/40967938/jpmorgan-ceo-jamie-dimon-calls-for-federal-employees-to-return-to-office-says-empty-buildings-bother?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">JPMorgan CEO Jamie Dimon Calls For Federal Employees To Return To Office, Says Empty Buildings &#8216;Bother&#8217; Him: &#8216;I Can&#8217;t Believe&#8230;&#8217;</a>
Why It Matters: This development follows the <a href="https://www.benzinga.com/news/24/09/40931809/house-republicans-reject-their-own-funding-bill-as-government-shutdown-looms-mike-johnson-says-we-ha">rejection</a> of Speaker Johnson&#8217;s initial funding bill by House Republicans. The failure of the bill complicated efforts to avert a government shutdown at the end of the month.
Earlier, Senate Majority Leader, Chuck Schumer (D-N.Y.), had warned of potential blame for a government shutdown due to "Republican poison pills." He cautioned that the American public would hold Republicans accountable if a shutdown occurs.
Photo via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

House GOP Leaders Pitch 3-Month Funding Plan, Drop Trump-Backed Voter ID Proposal: Mike Johnson Says Shutting Government Down 40 Days From Election Is 'Political Malpractice'

With over 100 patents and 30 years of experience in food, pharmaceutical, and cannabis packaging, Jim Sanfilippo is transforming cannabis safety.
His groundbreaking cryogenic pasteurization technology at VIST Labs is solving one of the industry&#8217;s dirtiest secrets: microbial contamination.
Operating in a $35 billion market, Sanfilippo's innovations are crucial for cannabis brands striving to maintain product integrity while navigating complex regulatory challenges.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">From Nuts To Frozen Nuggs</h3>
Sanfilippo's expertise in packaging dates back to his family's food business, where his innovations in oxygen-free packaging for nuts led to breakthroughs in the food and pharmaceutical sectors. He has spent decades optimizing shelf life and safety. In 2017, after selling two divisions of his business to packing behemoth Sonoco, he turned his attention to cannabis.
&#8220;Cannabis is a $35 billion industry in the U.S.,&#8221; Sanfilippo said, noting that its microbial contamination issues are particularly concerning​.
<h3 class="wp-block-heading">Cryogenic Pasteurization: The Cannabis Industry's Dirty Little Secret</h3>
At the heart of <a href="https://vistlabs.com/">VIST Labs' breakthrough</a> is the cryogenic pasteurization process, which leverages medical-grade cryogenic vapor to<a href="https://www.benzinga.com/general/biotech/24/09/40820581/want-organic-cannabis-operators-are-turning-to-this-tech-to-save-millions-and-get-certified"> sterilize cannabis products</a> while preserving their natural properties. "Cannabis is heavily contaminated with yeast, mold, and pathogens like Aspergillus," Sanfilippo explained.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="685" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-1024x685.jpg" alt="" class="wp-image-559846" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-1024x685.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-300x201.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-768x513.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585.jpg 1300w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Courtesy of VIST </figcaption></figure>
He says that traditional methods, such as gamma <a href="https://www.benzinga.com/general/biotech/23/02/30699860/from-food-to-cannabis-buds-x-rays-are-transforming-supply-chains-an-expert-explains-how-and-why">radiation</a> or ozone, can damage cannabinoids and terpenes, leading to degraded quality.
How does it work?
<h3 class="wp-block-heading">Freeze Microbes! </h3>
VIST&#8217;s solution reduces oxygen levels to a point where oxidation and microbial growth are halted, without affecting the product's integrity​. The process begins by placing cannabis into a product cassette, holding 4-5 pounds. This cassette is loaded into the pasteurization machine &#8211; a refrigerator-sized unit &#8211; where the chamber is then prepared with cryogenic vapor.
In the next step, the vapor-induced sterilization chamber (VIST chamber) is activated. Inside this chamber, cryogenic vapor, which is created by boiling off liquid nitrogen at -320 degrees Fahrenheit, mixes with a medical-grade atmosphere.
Within 90 to 150 seconds, the vapor floods the chamber, bringing oxygen levels to extremely low concentrations (around 95% cryogenic vapor), which kills harmful microbial organisms like <a href="https://www.benzinga.com/markets/cannabis/24/07/39584632/mold-and-yeast-sixth-marijuana-recall-this-year-hits-colorado-cannabis-dispensaries">Aspergillus, E. coli, and Salmonella</a>.
After the sterilization, the product is quickly cools down using liquid nitrogen, preventing oxidation during the process. Finally, the cannabis is purified with a HEPA filtration system, removing any remaining airborne contaminants and ensuring stability as the product is packaged in aseptic, low-oxygen conditions​.
Read Also: <a href="https://www.benzinga.com/news/24/09/40941818/how-this-cheese-aging-tech-is-boosting-profits-for-cannabis-growers-stop-throwing-cheddar-out-the-do">How This Cheese-Aging Tech Is Boosting Profits For Cannabis Growers: Stop Throwing Cheddar Out The Door</a>
<h3 class="wp-block-heading">A Modular Solution For Cannabis Business</h3>
VIST Labs' cryogenic pasteurization machines are designed to be modular, offering flexibility for mid-sized cultivators as well as large-scale operations. "We can run it in cassette mode at 25 pounds per hour, or upgrade to our high-output configuration, reaching up to 40 pounds per hour," Sanfilippo told Benzinga.
VIST Labs' cryogenic pasteurization system isn't just a machine, it's a<a href="https://www.benzinga.com/general/biotech/23/08/33579692/cannabis-robots-meet-the-company-boosting-efficiency-and-margins-through-packaging-automation"> fully integrated packaging solution</a>. After the sterilization process, the product is transferred into a bulk device that packs cannabis into different bag sizes, from one to ten-pound bags, or a pouch line for smaller quantities like an eighth-ounce. &#8220;We have the cooler, a pouch bagger, and other parts working together to maintain the product in a near-zero oxygen atmosphere," Sanfilippo explained.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="600" height="600" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment.png" alt="" class="wp-image-559842" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment.png 600w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment-300x300.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment-150x150.png 150w" sizes="(max-width: 600px) 100vw, 600px" /><figcaption class="wp-element-caption">Courtesy of VIST </figcaption></figure>
This scalability makes VIST's technology accessible to a wide range of businesses, whether they are aiming for compliance in medical markets or looking to protect their medical-grade level crop for export.
The company's aseptic packaging solutions meet European Pharmacopoeia standards, ensuring <a href="https://www.benzinga.com/markets/cannabis/24/06/39442869/2-9b-european-cannabis-market-a-strategic-blueprint-for-cross-border-transportation-logistics">compliance </a>in both domestic and international markets.
VIST's technology is also forward-thinking, preparing cannabis brands for potential federal legalization. With the increasing possibility of federal oversight, Sanfilippo notes that stricter regulations, especially around truth-in-labeling, will make compliance technologies like theirs essential for long-term success.
&#8220;With our system, we're offering crop-year protection and complete microbial control for up to a year," Sanfilippo said, noting that VIST expects to pack close to 150 million pounds of outdoor-grown cannabis in 2023 alone​.
<h3 class="wp-block-heading">Contamination And Mislabeling&#8230;Not A Problem</h3>
Beyond decontamination, VIST's system tackles a major issue in the cannabis industry: the degradation of THC potency over time. Inconsistent oxygen levels in packaging lead to mislabeled products, which can result in recalls and regulatory action.
&#8220;Within 45 to 50 days, THC levels can degrade by 10% or more, rendering the label claims false,&#8221; said Sanfilippo. VIST's modified atmosphere packaging (MAP) ensures stability for up to a year, keeping products compliant and safe.
Read Next: <a href="https://www.benzinga.com/general/biotech/24/08/40298228/think-you-can-do-it-all-20-000-reasons-why-automation-outperforms-a-broad-approach-in-cannabis">Think You Can Do It All? 20,000 Reasons Why Automation Outperforms A Broad Approach In Cannabis</a>

Cannabis

Entrepreneurship

Management

Success Stories

Small Business

Exclusives

Interview

X-Rays, Microwaves And Now What? This Company Freezes Weed At -320°F To Kill Mold And Save A Ton

This week, the Federal Reserve's decision to reduce interest rates by 50 basis points boosted share prices across the technology, construction, <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40937291/bank-stocks-hit-inflection-point-after-feds-50-basis-point-cut-analyst-reveal-top-p" rel="noreferrer noopener">industrial, machinery, and financial sectors</a>.
These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Edgewise Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) shares rocketed 50.19% after the company announced topline data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm of the Phase 2 CIRRUS-<a href="https://www.benzinga.com//node/40940696" target="_blank" rel="noreferrer noopener">HCM trial in patients with obstructive HCM</a>.</li>
<li>Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) stock gained 28.36% after <a href="https://www.benzinga.com//node/40884021" target="_blank" rel="noreferrer noopener">reportedly considering a sale</a>.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) shares upped 27.06%. The company's subsidiary Bausch + Lomb Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) <a href="https://www.benzinga.com//node/40884021" target="_blank" rel="noreferrer noopener">is reportedly considering a sale</a>.</li>
<li>Ascendis Pharma A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) stock gained 26.87% last week after the company announced <a href="https://www.benzinga.com//node/40882593" target="_blank" rel="noreferrer noopener">topline data from</a> its pivotal approach trial of a rare dwarfism candidate.</li>
<li>Nuvalent Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>) stock gained 23.50% after the company <a href="https://www.benzinga.com//node/40865049" target="_blank" rel="noreferrer noopener">highlighted results for its ROS1 and ALK-Positive NSCLC programs</a> and accelerated its development timeline. The company also announced a $350 million public offering, and multiple firms raised their respective <a href="https://www.benzinga.com/quote/nuvl/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) stock gained 22.61% last week as stocks in the broader industrial space jumped following the Fed's announcement to cut rates by 50 basis points, which could support investment and economic growth.</li>
<li>GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) shares jumped 21.28%.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972008/constellation-energy-li-auto-and-carvana-are-among-top-11-large-cap-gainers-last-week-sept-16-sept" target="_blank" rel="noreferrer noopener">Constellation Energy, Li Auto And Carvana Are Among Top 11 Large Cap Gainers Last Week (Sept 16-Sept 20): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972060/novo-nordisk-chewy-and-fedex-are-among-top-10-large-cap-losers-last-week-sept-15-sept-21-are-the-o" target="_blank" rel="noreferrer noopener">Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Mid Cap

ASND

BLCO

EWTX

NUVL

POWL

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) stock declined 23.61%. The company announced that data for the novel, potential first-in-class investigational bispecific antibody, ivonescimab, was presented <a href="https://www.benzinga.com//node/40873837" target="_blank" rel="noreferrer noopener">at the 2024 ESMO Annual Meeting</a>.</li>
<li>Joint Stock Company Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) stock tumbled 21.66% after Culper Research <a href="https://www.benzinga.com//node/40943334" target="_blank" rel="noreferrer noopener">issued a short report on the company</a>.</li>
<li>BioMarin Pharmaceutical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) stock lost 16.74% last week <a href="https://www.benzinga.com//node/40885653" target="_blank" rel="noreferrer noopener">following strong dwarfism drug data</a> from rival Ascendis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>).</li>
<li>Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) lost 13.26% <a href="https://www.benzinga.com//node/40961732" target="_blank" rel="noreferrer noopener">last week</a>.</li>
<li>FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) stock fell 11.08% after the company reported worse-than-expected Q1 financial results and <a href="https://www.benzinga.com//node/40948046" target="_blank" rel="noreferrer noopener">cut FY25 guidance</a>.</li>
<li>BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) stock decreased 9.01%. Pfizer, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and BioNTech received positive CHMP opinion for omicron KP.2-adapted <a href="https://www.benzinga.com//node/40956192" target="_blank" rel="noreferrer noopener">COVID-19 vaccine in the European Union</a>.</li>
<li>Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) stock fell 7.17%. Several analysts raised <a href="https://www.benzinga.com/quote/ajg/analyst-ratings" target="_blank" rel="noreferrer noopener">the price target on the stock</a>.</li>
<li>Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) shares declined 6.97% after the company announced a selling stockholder&#8217;s public offering of shares <a href="https://www.benzinga.com//node/40949015" target="_blank" rel="noreferrer noopener">and a concurrent share repurchase</a>.</li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) stock fell 6.93% after <a href="https://www.benzinga.com//node/40961934" target="_blank" rel="noreferrer noopener">headline results from the mid-stage study</a> of monlunabant in obese patients.</li>
<li>Murphy USA Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUSA#NYSE">MUSA</a>) shares fell 6.90% after JP Morgan downgraded the stock from Neutral to Underweight but raised its <a href="https://www.benzinga.com/quote/musa/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $415 to $435</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972008/constellation-energy-li-auto-and-carvana-are-among-top-11-large-cap-gainers-last-week-sept-16-sept" target="_blank" rel="noreferrer noopener">Constellation Energy, Li Auto And Carvana Are Among Top 11 Large Cap Gainers Last Week (Sept 16-Sept 20): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Uniti Group

Uniti Group (UNIT) Forecast

Uniti Group (NASDAQ:UNIT) Stock, Quote.Headers.trade-ideas